Fennec Pharmaceuticals Inc (FENC)
Healthcare
Biotechnology
9.60 $
-3.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Fennec Pharmaceuticals Inc (FENC)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 48.9% of the shares are freely tradable; institutional investors hold 54.3%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
54.3%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
14.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
48.9%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
1.5%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
35Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | 8.37 | 2,908,201 | +11.3 | 03/31/2026 |
| Southpoint Capital Advisors LP | 7.90 | 2,744,741 | +0.0 | 03/31/2026 |
| Solas Capital Management LLC | 7.15 | 2,482,198 | -3.1 | 03/31/2026 |
| AIGH Capital Management, LLC | 5.70 | 1,981,501 | +25.3 | 03/31/2026 |
| BlackRock Inc | 3.94 | 1,368,176 | +10.8 | 03/31/2026 |
| Vanguard Group Inc | 3.07 | 1,067,651 | +11.7 | 12/31/2025 |
| Vanguard Capital Management, LLC | 2.58 | 897,144 | +0.0 | 03/31/2026 |
| Awm Investment Company Inc | 2.07 | 720,135 | +1.2 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.51 | 873,030 | +0.0 | 04/30/2026 |
| iShares Russell 2000 ETF | 1.83 | 634,892 | +0.9 | 05/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.